News for Emergent BioSolutions Inc. (0IGA.L)

Stocks in news: IndusInd Bank, Hindustan Zinc, IIFL Finance, BEL, NTPC and more

PR NewswireBANGALORE, India, March 10, 2025 Expected to enhance global innovator flexibility with biologics drug substance facility in BaltimoreBANGALORE,

**media[562046]**

California-based GigaCloud Technology Inc. (GCT) is down over 21 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Total Revenue (Q4 2024): $195 million, down from the prior year.Adjusted EBITDA (Q4 2024): $21 million, an increase of $18 million year-over-year.Adjusted Gros

Mar 03, 2025 / 10:00PM GMTOperator Good day and thank you for standing by. Welcome to Merchant buyer Solutions Inc. fourth quarter 2024 earnings conference call

Emergent BioSolutions Inc. (NYSE:EBS) Q4 2024 Earnings Conference Call March 3, 2025 6:00 AM ETCompany ParticipantsFrank Vargo - Assistant TreasurerJoseph...

The following slide deck was published by Emergent BioSolutions Inc.

Fourth Quarter 2024 Total Revenues of $194.7 million; Full Year 2024 Total Revenues of $1.04 billionFourth Quarter 2024 Net Loss of $31.3 million, decrease in N

Revenue: $194.7 million for Q4 2024, missing the estimated $254.67 million, reflecting a 30% decline from the previous year.Net Loss: $31.3 million for Q4 2024

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%, down from 50.9% in January.

Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA)

Separately, Company leaders will attend and present at J.P. Morgan's 2025 Leveraged Finance Conference on February 24, 2025 GAITHERSBURG, Md., Feb. 18, 2025

**media[534991]**

Shares of Emergent BioSolutions Inc (EBS) surged 3.78% in mid-day trading on Jan 31. The stock reached an intraday high of $11.60, before settling at $11.53,

Shares of Emergent BioSolutions Inc (EBS) surged 3.40% in mid-day trading on Jan 24. The stock reached an intraday high of $11.98, before settling at $11.87,

**media[513868]**

**media[509200]**

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.7% on Monday. The Dow traded down 0.67% to 42,702.02 while the NASDAQ fel...